This is compared to 83% ... Trial of Cell-Based Therapy for High-Risk Lymphoma Leads to FDA Breakthrough Designation July 10, 2024 — CAR-T cell therapy helps some with intractable lymphoma ...

Xencor Inc . (NASDAQ:XNCR), a biopharmaceutical company specializing in innovative therapies for immunology and oncology, ...

Lymphoma is a type of cancer that begins in immune system cells, called lymphocytes. It generally presents as a solid tumor of lymphoid cells and can develop in the lymph nodes, spleen ...

How do step-up dosing protocols reduce CRS risk in patients with high-risk disease, and when might you modify this approach? (Dr Allan) How do you incorporate infection prevention strategies, such ...

Diffuse large B-cell lymphoma is the most prevalent non-Hodgkin lymphoma among the elderly. Yet, limited data exists on how best to treat older patients with this disease because their comorbidities ...

Innovative research for a dog cancer treatment from the University of Missouri College of Veterinary Medicine has shown early ...

On World Cancer Day, Mamta Mohandas, Yuvraj Singh, Lisa Ray, and others inspire with their cancer survival stories.

The lack of one or more of the critical genetic alterations would not allow AtLP to behave as fully developed lymphomas. It is possible that AtLP represent multiclonal B cells, T cells or NK-cell ...

A WHO-commissioned study by Australian researchers finds no evidence linking mobile phone use to various cancers, including ...

Future Oncol. 2014;10(15):2509-2528.

AdvanCell, an Australia-based radiopharmaceutical company, has raised $112m as investor interest in the radiopharma sector ...